Pain



Pain







  • Evaluation



    • General—a subjective experience involving physical, emotional, and cognitive dimensions


    • Mechanism



      • Nociceptive pain—receptors triggered by tissue injury



        • Visceral pain (internal organ pain)



          • Pain in hollow organs is poorly localized, crampy, and/or colicky.


          • Pain in solid organs is poorly localized, achy, and/or dull.


        • Somatic pain—more easily localized, achy, dull, and/or throbbing


      • Neuropathic pain—due to pathologic effects on the central or peripheral nervous system



        • Described as a radiating electric sensation; can also be sharp and burning.


        • Associated with paresthesias, dysesthesias, hyperalgesia, or allodynia.



    • Classification



      • Acute—typically follows an injury, but can be de novo; usually improves as tissue heals.


      • Chronic—pain lasting 3 to 6 months or pain which lasts 1 month longer than expected.


    • Assessment



      • Scales



        • Numeric rating scale (1-10).


        • Visual analogue scale (image to image).


      • Frequent reevaluation is key


  • Management



    • Pain management as outlined by the World Health Organization (WHO) Analgesic Ladder (Table 2.44.1)


  • Treatment—aim for the lowest possible effective dose to minimize side effects.



    • Non-Nonsteroidal anti-inflammatory drugs (NSAID) analgesics



      • Acetaminophen (Tylenol) 325 to 650 mg PO q4h



        • Maximum dose is 1 g per dose; no more than 4 g per 24 hours.


        • For those with liver disease, decrease dose as there is a danger for liver toxicity.





      • Side effects



        • Gastrointestinal (GI) ulceration/bleeding



          • Therefore, consider coadministration with a proton pump inhibitor (PPI).


        • Potential nephrotoxicity in those with renal disease as well as in the elderly


      • Medications



        • Aspirin 325 to 650 mg PO/PR q4h



        • Ibuprofen (Motrin, Advil) 200 to 800 mg PO q6h


        • Naproxen (Naprosyn, Aleve) 250 to 500 mg PO q8h


        • Piroxicam (Feldene) 20 mg PO daily


        • Diclofenac (Voltaren, Cataflam) 50 mg PO q8h


    • Cyclooxygenase-2 (COX-2) specific inhibitors



      • Celecoxib (Celebrex) 200 mg PO BID



        • May have less GI effects than NSAIDS, but be careful with increased cardiovascular risk.


    • Weak opioids and opioid-like medications



      • Propoxyphene HCl (Darvon) 65 mg PO q4h = propoxyphene napsylate 100 mg PO q4h



        • Be careful with continued use as active metabolites accumulate over time.


      • Tramadol (Ultram) 50 to 100 mg PO q6h.



        • May trigger seizures; therefore, avoid in such patients.


    • Strong opioids

Aug 28, 2016 | Posted by in PSYCHIATRY | Comments Off on Pain

Full access? Get Clinical Tree

Get Clinical Tree app for offline access